Enoxaparin Sodium Injection
Product Images NDC 25021-410

Product Visual Gallery

This gallery contains 31 technical images submitted to the FDA as part of the official labeling for Enoxaparin Sodium (NDC 25021-410). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sagent Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure (Eno0i 0000 01)

An instructional illustration showing two hands holding a syringe and a cap, with arrows indicating the removal of the cap from the syringe before administration. This diagram visually guides the proper preparation of an injection device, relevant to subcutaneous administration.*

FDA Label Image

Figure (Eno0i 0000 02)

An instructional illustration showing a hand holding a syringe and injecting into the skin of the opposite hand, indicating the subcutaneous injection method.*

FDA Label Image

Figure (Eno0i 0000 03)

An instructional illustration showing a hand administering a subcutaneous injection using a syringe. The syringe is positioned at an angle to the skin, indicating the method for injecting Enoxaparin Sodium injection subcutaneously.*

FDA Label Image

Figure (Eno0i 0000 04)

An instructional black and white line drawing showing a hand holding a syringe with an arrow indicating to push a plunger or mechanism. The image appears to demonstrate part of the injection preparation or administration process for a medication.*

FDA Label Image

Figure (Eno0i 0000 05)

An instructional illustration showing a hand disposing of a needle into a container marked with a biohazard symbol. The image indicates safe needle disposal for injectable products such as Enoxaparin Sodium.*

FDA Label Image

Figure (Eno0i 0000 06)

Chemical structure of Enoxaparin Sodium showing its polysaccharide chain with repeating disaccharide units and specific substituents as defined by R1 and R2 groups.*

FDA Label Image

Figure (Eno0i 0000 07)

Chemical structure diagram of Enoxaparin Sodium, depicting rings and functional groups typical of this active ingredient.*

FDA Label Image

Figure (Eno0i 0000 08)

A forest plot chart depicting relative risk comparisons between Enoxaparin Sodium (Enox) and unfractionated heparin (UFH) across multiple patient subgroups. The chart shows subgroup categories such as sex, age, infarct location, diabetes status, prior myocardial infarction, fibrinolytic agent type, time to treatment, and PCI in 30 days. Risk percentages for UFH and Enox, as well as reduction in risk, are listed alongside each subgroup. Overall risk reduction favors Enoxaparin sodium.*

FDA Label Image

Figure (Eno0i 0000 09)

A Kaplan-Meier curve showing the hazard distribution function over time to death or myocardial re-infarction in days, comparing Enoxaparin Sodium injection to UFH (unfractionated heparin). The main graph covers a 30-day period, with Enoxaparin showing a lower hazard than UFH. An inset graph extends the comparison to 1 year. Risk population counts are shown below the x-axis for both treatments at various time points.*

FDA Label Image

Figure (Eno0i 0000 10)

Instructional diagram showing a syringe before and after use. The 'Before Use' side labels the plunger rod, needle, and needle cap. The 'After Use' side shows the plunger rod and a protective sleeve covering the needle.*

FDA Label Image

Figure (Eno0i 0000 11)

Illustration labeled Figure A depicting the contents of an Enoxaparin sodium prefilled syringe kit. It includes one cotton ball or gauze, one alcohol wipe, one small adhesive bandage, a sharps disposal container, and the prefilled syringe itself.*

FDA Label Image

Figure (Eno0i 0000 12)

An instructional illustration showing a person peeling back a protective cover from a syringe, demonstrating preparation for use of an injection device, likely related to Enoxaparin Sodium injection for subcutaneous administration.*

FDA Label Image

Figure (Eno0i 0000 13)

An illustration labeled Figure C showing a syringe with an arrow pointing to the 'Expiration Date' area on the barrel. The syringe is intended for subcutaneous injection.*

FDA Label Image

Figure (Eno0i 0000 14)

An instructional illustration labeled Figure D, showing a syringe filled with a clear liquid. The syringe includes a plunger and needle cap, highlighting the transparent liquid inside the barrel.*

FDA Label Image

Figure (Eno0i 0000 15)

An anatomical illustration showing the lower back and upper buttocks area with two shaded rectangular regions indicating possible injection sites for subcutaneous administration.*

FDA Label Image

Figure (Eno0i 0000 16)

An instructional line drawing illustrating the application of a patch or injection site on the lower abdominal area. The person uses their fingers to press a small square item on the skin near the waistline, suggesting proper placement technique for subcutaneous administration.*

FDA Label Image

Figure (Eno0i 0000 17)

An instructional line drawing showing two hands: one holding an injection syringe with a protective cap on the needle, and the other hand pulling the cap away from the syringe needle. Two arrows between the hands indicate the motion of removing the needle cap.*

FDA Label Image

Figure (Eno0i 0000 18)

An instructional line drawing illustrating how to adjust the dose of a prefilled syringe injection. The image shows a hand holding a syringe with a plunger being pushed down, accompanied by an arrow pointing downward and the instruction "Set your dose." This diagram is related to administering Enoxaparin Sodium injection subcutaneously.*

FDA Label Image

Figure (Eno0i 0000 19)

Illustration showing a hand pinching the skin on a person's lower abdomen, demonstrating the proper technique for subcutaneous injection, relevant to Enoxaparin Sodium injection administration.*

FDA Label Image

Figure (Eno0i 0000 20)

An instructional illustration showing the technique for administering a subcutaneous injection. It depicts an arm with a syringe held at a 90-degree angle to the skin, indicating proper injection method for Enoxaparin Sodium injection.*

FDA Label Image

Figure (Eno0i 0000 21)

An instructional illustration showing a hand administering a subcutaneous injection with a syringe into the upper thigh area. The image depicts the needle insertion angle and hand positioning for proper injection technique.*

FDA Label Image

Figure (Eno0i 0000 22)

An instructional diagram showing how to administer a subcutaneous injection using a syringe. The image depicts a hand lifting skin at the abdomen while positioning the syringe at an angle to inject beneath the skin.*

FDA Label Image

Figure (Eno0i 0000 23)

An instructional diagram showing a hand holding an Enoxaparin Sodium injection syringe with a protective sleeve. The image indicates a 'click' sound as the sleeve moves forward, demonstrating part of the injection preparation process.*

FDA Label Image

Figure (Eno0i 0000 24)

An instructional illustration showing a hand holding an Enoxaparin Sodium injection syringe above a sharps disposal container. The needle cap is being removed or about to be disposed in the sharps container, demonstrating safe syringe disposal procedures for subcutaneous injection use.*

FDA Label Image

Package Label – Principal Display Panel – Syringe Blister Label (Eno0i 0000 25)

Label for Enoxaparin Sodium Injection, USP, featuring 30 mg per 0.3 mL strength. It specifies a single-dose syringe with an automatic safety device for subcutaneous injection. Manufactured by Sagent Pharmaceuticals, the label includes storage instructions and a barcode.*

FDA Label Image

Package Label – Principal Display Panel – Syringe Blister Label (Eno0i 0000 26)

Label for Enoxaparin Sodium Injection, USP 40 mg per 0.4 mL in a single-dose syringe. The syringe contains 0.4 mL of solution for subcutaneous injection. Manufactured for Sagent Pharmaceuticals with a barcode and storage instructions to keep at 20° to 25°C. Includes warnings and directions to see the package insert for dosage details.*

FDA Label Image

Package Label – Principal Display Panel – Syringe Blister Label (Eno0i 0000 27)

Enoxaparin Sodium Injection, USP 60 mg per 0.6 mL single-dose syringe label from Sagent Pharmaceuticals. The orange and white label indicates subcutaneous injection, automatic safety device, and storage instructions. It includes dosage information, barcode, manufacturer details, lot, and expiration date areas.*

FDA Label Image

Package Label – Principal Display Panel – Syringe Blister Label (Eno0i 0000 28)

Label for Enoxaparin Sodium Injection, USP 80 mg per 0.8 mL single-dose syringe. The label includes dosage form (injection) and route (subcutaneous), a barcode, manufacturer Sagent Pharmaceuticals, and storage instructions at 20° to 25°C. It also contains warnings and usage directions along with batch and expiration details on a peel-away section.*

FDA Label Image

Package Label – Principal Display Panel – Syringe Blister Label (Eno0i 0000 29)

The label is for Enoxaparin Sodium Injection, USP, 100 mg per mL in a single-dose syringe with an automatic safety device for subcutaneous injection. It includes dosage form and strength, manufacturer Sagent Pharmaceuticals, and storage instructions. The label features barcode and lot/expiration date peel sections.*

FDA Label Image

Package Label – Principal Display Panel – Syringe Blister Label (Eno0i 0000 30)

Label for Enoxaparin Sodium Injection, USP 120 mg per 0.8 mL in a single-dose safety syringe for subcutaneous injection. The label includes storage instructions, dosage information, and manufacturer details, showing Sagent Pharmaceuticals as the labeler. It also displays the NDC number and a barcode.*

FDA Label Image

Package Label – Principal Display Panel – Syringe Blister Label (Eno0i 0000 31)

Label for Enoxaparin Sodium Injection USP 150 mg/mL, single-dose syringe with automatic safety device for subcutaneous injection. Labeled strength is 150 mg per mL in a 1 mL syringe. Manufactured by Sagent Pharmaceuticals, Schaumburg, IL, USA. The label includes usage instructions, storage conditions (20° to 25°C), barcode, lot number, expiration date fields, and a peel strip for batch detail access.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.